Patents by Inventor Christopher Kovalchick

Christopher Kovalchick has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Closed loop control of physiological glucose
    Patent number: 11901060
    Abstract: The present disclosure relates to systems and methods for controlling physiological glucose concentrations in a patient.
    Type: Grant
    Filed: December 14, 2018
    Date of Patent: February 13, 2024
    Assignee: Ypsomed AG
    Inventors: Yamei Chen, Haoda Fu, Parag Garhyan, Ahmad Mohamad Haidar, Richard Earl Jones, Jr., Christopher Kovalchick, Marie Kearney Schiller, Monica Rixman Swinney, Howard Allan Wolpert
  • Infusion set with components comprising a polymeric sorbent to reduce the concentration of m-cresol in insulin
    Patent number: 11045601
    Abstract: An insulin infusion set (IIS) device with one or more features designed to achieve longevity in a patients continuous subcutaneous insulin infusion (CSII) site viability. One exemplary feature is an adsorbent material configured to adsorb phenolic excipients (e.g., m-cresol or other preservatives) from the insulin formulation. The adsorbent material may be positioned along a fluid pathway specifically designed to increase and/or extend exposure between the insulin formulation and the adsorbent material. Another exemplary feature is a medicament configured to reduce the patients inflammation or slow the progression of the patients inflammatory response. Yet another exemplary feature is a diffusive catheter configured to deliver the insulin formulation in a diffuse manner.
    Type: Grant
    Filed: April 21, 2017
    Date of Patent: June 29, 2021
    Assignee: Eli Lilly and Company
    Inventors: Christopher John Demaria, Daniel Morris Hartmann, Graham Barry Jones, Christopher Kovalchick, Sean Matthew Pszenny, Rhea Sirkar, Monica Rixman Swinney
  • CLOSED LOOP CONTROL OF PHYSIOLOGICAL GLUCOSE
    Publication number: 20200342974
    Abstract: The present disclosure relates to systems and methods for controlling physiological glucose concentrations in a patient.
    Type: Application
    Filed: December 14, 2018
    Publication date: October 29, 2020
    Inventors: Yamei CHEN, Haoda FU, Parag GARHYAN, Ahmad Mohamad HAIDAR, Richard Earl JONES, Jr., Christopher KOVALCHICK, Marie Kearney SCHILLER, Monica Rixman SWINNEY, Howard Allan WOLPERT
  • INFUSION SET WITH COMPONENTS COMPRISING A POLYMERIC SORBENT TO REDUCE THE CONCENTRATION OF M-CRESOL IN INSULIN
    Publication number: 20190054233
    Abstract: An insulin infusion set (IIS) device with one or more features designed to achieve longevity in a patients continuous subcutaneous insulin infusion (CSII) site viability. One exemplary feature is an adsorbent material configured to adsorb phenolic excipients (e.g., m-cresol or other preservatives) from the insulin formulation. The adsorbent material may be positioned along a fluid pathway specifically designed to increase and/or extend exposure between the insulin formulation and the adsorbent material. Another exemplary feature is a medicament configured to reduce the patients inflammation or slow the progression of the patients inflammatory response. Yet another exemplary feature is a diffusive catheter configured to deliver the insulin formulation in a diffuse manner.
    Type: Application
    Filed: April 21, 2017
    Publication date: February 21, 2019
    Inventors: Christopher John DEMARIA, Daniel Morris HARTMANN, Graham Barry JONES, Christopher KOVALCHICK, Sean Matthew PSZENNY, Rhea SIRKAR, Monica Rixman SWINNEY
  • Drug delivery device with insertion mechanism button safety
    Patent number: D805631
    Type: Grant
    Filed: January 21, 2016
    Date of Patent: December 19, 2017
    Assignee: Becton, Dickinson and Company
    Inventors: Charles George Hwang, John Prudden, Christopher Kovalchick, Russell Cole, Leya Colavito, Alessandro Pizzochero, J. Richard Gyory, Justin Cumming, Kurt Maw
  • Wearable drug delivery device with adhesive
    Patent number: D829889
    Type: Grant
    Filed: January 21, 2016
    Date of Patent: October 2, 2018
    Assignee: BECTON, DICKINSON AND COMPANY
    Inventors: Charles George Hwang, John Prudden, Christopher Kovalchick, Russell Cole, Andrew Allegretti, Jeffrey Reed, Leya Colavito, Alessandro Pizzochero, J. Richard Gyory, Justin Cumming, Kurt Maw
  • Wearable drug delivery device baseplate
    Patent number: D829894
    Type: Grant
    Filed: January 21, 2016
    Date of Patent: October 2, 2018
    Assignee: BECTON, DICKINSON AND COMPANY
    Inventors: Charles George Hwang, John Prudden, Christopher Kovalchick, Russell Cole, Nir Swenson, Gail Siewiorek, Joseph Iskandar, Alessandro Pizzochero
  • Wearable drug delivery device with adhesive and liner
    Patent number: D830537
    Type: Grant
    Filed: January 21, 2016
    Date of Patent: October 9, 2018
    Assignee: BECTON, DICKINSON AND COMPANY
    Inventors: Charles George Hwang, John Prudden, Christopher Kovalchick, Russell Cole, Andrew Allegretti, Jeffrey Reed, Leya Colavito, Alessandro Pizzochero, J. Richard Gyory, Justin Cumming, Kurt Maw
  • Adhesive liner for wearable drug delivery device
    Patent number: D830547
    Type: Grant
    Filed: January 21, 2016
    Date of Patent: October 9, 2018
    Assignee: BECTON, DICKINSON AND COMPANY
    Inventors: Charles George Hwang, John Prudden, Christopher Kovalchick, Leya Colavito, Alessandro Pizzochero, J. Richard Gyory
  • Adhesive liner for wearable drug delivery device
    Patent number: D836193
    Type: Grant
    Filed: February 6, 2018
    Date of Patent: December 18, 2018
    Assignee: BECTON, DICKINSON AND COMPANY
    Inventors: Charles George Hwang, John Prudden, Christopher Kovalchick, Leya Colavito, Alessandro Pizzochero, J. Richard Gyory
  • Wearable drug delivery device
    Patent number: D857191
    Type: Grant
    Filed: January 21, 2016
    Date of Patent: August 20, 2019
    Assignee: Becton, Dickinson and Company
    Inventors: Charles George Hwang, John Prudden, Christopher Kovalchick, Russell Cole, Andrew Allegretti, Jeffrey Reed, Nir Swenson, Gail Siewiorek, Joseph Iskandar, Alessandro Pizzochero, J. Richard Gyory, Justin Cumming, Kurt Maw
  • Wearable drug delivery device
    Patent number: D878552
    Type: Grant
    Filed: March 7, 2019
    Date of Patent: March 17, 2020
    Assignee: Becton, Dickinson and Company
    Inventors: Charles George Hwang, John Prudden, Christopher Kovalchick, Russell Cole, Andrew Allegretti, Jeffrey Reed, Nir Swenson, Gail Siewiorek, Joseph Iskandar, Alessandro Pizzochero, J. Richard Gyory, Justin Cumming, Kurt Maw
  • Wearable drug delivery device
    Patent number: D878553
    Type: Grant
    Filed: June 25, 2019
    Date of Patent: March 17, 2020
    Assignee: Becton, Dickinson and Company
    Inventors: Charles George Hwang, John Prudden, Christopher Kovalchick, Russell Cole, Andrew Allegretti, Jeffrey Reed, Nir Swenson, Gail Siewiorek, Joseph Iskandar, Alessandro Pizzochero, J. Richard Gyory, Justin Cumming, Kurt Maw